FDA Approves Marketing That Cites Yogurt's Ability to Reduce Diabetes Risk

FDA Approves Marketing That Cites Yogurt's Ability to Reduce Diabetes Risk

FDA Approves Marketing , That Cites Yogurt's Ability , to Reduce Diabetes Risk.

NBC reports that the Food and Drug Administration has decided that food makers can advertise that regularly consuming yogurt could reduce the risk of Type 2 diabetes.

NBC reports that the Food and Drug Administration has decided that food makers can advertise that regularly consuming yogurt could reduce the risk of Type 2 diabetes.

The decision comes following a 2018 petition from Danone North America, which owns major yogurt brands Dannon, Activia, Wallaby Organic and Silk.

.

The decision comes following a 2018 petition from Danone North America, which owns major yogurt brands Dannon, Activia, Wallaby Organic and Silk.

.

The petition sought to have the FDA allow the company to market yogurt's ability to reduce the risk of Type 2 diabetes without objection.

On March 1, the FDA confirmed that it would not oppose the marketing campaign, while including some caveats.

.

Those caveats include that the marketing must note that evidence is limited to eating two cups, equal to three servings, of yogurt per week.

.

NBC reports that Danone's petition is part of a standard process which the FDA calls "qualified health claims.".

While these claims do not require the FDA's approval, companies often petition the agency to define the specific language necessary to avoid making false claims. The petition reportedly cited yogurt's nutrient profile of proteins, vitamins and low sodium.

The petition also cited studies which have supported the link between regularly consuming yogurt and reduced risk of diabetes and related conditions.

The petition also noted that the evidence supports the health effects of yogurt as a food rather than related to any single nutrient or compound and thus is independent of fat or sugar content.

, FDA announcement, via NBC